| Metric | შპს მედექს | შპს Linema Pharm | შპს ირისე |
|---|---|---|---|
| Growth | |||
| Revenue | ₾5.0m₾3.3m | ₾3.9m₾1.6m | ₾3.6m₾4.2m |
| Revenue growth | 49.8% | 139.8% | -16.1% |
| Profitability | |||
| EBITDA | ₾1.4m₾978k | ₾1.3m₾465k | ₾545k₾934k |
| EBITDA margin | 28.9%29.5% | 32.2%28.7% | 15.3%22.0% |
| Net profit | ₾1.3m₾1.1m | ₾1.2m-₾90k | ₾378k₾747k |
| Net margin | 27.0%34.4% | 31.0%-5.5% | 10.6%17.6% |
| Balance sheet | |||
| Total assets | ₾3.0m₾1.7m | ₾7.5m₾6.2m | ₾2.5m₾2.6m |
| Total equity | ₾664k₾515k | ₾6.4m₾5.4m | ₾2.1m₾2.3m |
| ROE | 201.6%221.5% | 18.9%-1.6% | 18.2%32.9% |